ETF constituents for IBRN

Below, a list of constituents for IBRN (iShares Neuroscience and Healthcare ETF) is shown. In total, IBRN consists of 63 securities.

Note: The data shown here is as of date May 30, 2025 (the latest that can be sourced directly from the fund provider).

Click here to go back to the full list of ETFs.

Ticker Name Sector Asset Class Market Value Weight (%)
SRRK SCHOLAR ROCK HOLDING CORP Health Care Equity 148870.26 4.54
326030 SK BIOPHARMACEUTICALS LTD Health Care Equity 146970.95 4.48
NBIX NEUROCRINE BIOSCIENCES INC Health Care Equity 143789.36 4.38
XENE XENON PHARMACEUTICALS INC Health Care Equity 141882.9 4.32
ACAD ACADIA PHARMACEUTICALS INC Health Care Equity 140722.68 4.29
DNLI DENALI THERAPEUTICS INC Health Care Equity 136472.45 4.16
BIIB BIOGEN INC Health Care Equity 135511.61 4.13
ARGX ARGENX SE ADR Health Care Equity 135048.9 4.11
PTCT PTC THERAPEUTICS INC Health Care Equity 134798.4 4.11
SUPN SUPERNUS PHARMACEUTICALS INC Health Care Equity 134243.68 4.09
ALKS ALKERMES Health Care Equity 129403.03 3.94
HLUN B H. LUNDBECK CLASS B Health Care Equity 122961.99 3.75
CPRX CATALYST PHARMACEUTICALS INC Health Care Equity 120673.7 3.68
BHVN BIOHAVEN LTD Health Care Equity 101126.37 3.08
DYVOX DYNAVOX GROUP Information Technology Equity 90797.03 2.77
EWTX EDGEWISE THERAPEUTICS INC Health Care Equity 81216.45 2.47
NEU NEUREN PHARMACEUTICALS LTD Health Care Equity 81142.32 2.47
4592 SANBIO LTD Health Care Equity 71713.8 2.19
DYN DYNE THERAPEUTICS INC Health Care Equity 65202.48 1.99
IART INTEGRA LIFESCIENCES HOLDINGS CORP Health Care Equity 64687.44 1.97
AVDL AVADEL PHARMACEUTICALS ORD Health Care Equity 62852.7 1.92
PRAX PRAXIS PRECISION MEDICINES INC Health Care Equity 61519.15 1.87
AVXL ANAVEX LIFE SCIENCES CORP Health Care Equity 61147.04 1.86
BIOA B BIOARCTIC CLASS B Health Care Equity 59439.16 1.81
SRPT SAREPTA THERAPEUTICS INC Health Care Equity 57028.5 1.74
TSHA TAYSHA GENE THERAPIES INC Health Care Equity 39621.12 1.21
ZVRA ZEVRA THERAPEUTICS INC Health Care Equity 38191.35 1.16
AXGN AXOGEN INC Health Care Equity 37454.2 1.14
IDIA IDORSIA N LTD Health Care Equity 33892.21 1.03
AMLX AMYLYX PHARMACEUTICALS INC Health Care Equity 33646.09 1.03
DNTH DIANTHUS THERAPEUTICS INC Health Care Equity 33384.96 1.02
CAPR CAPRICOR THERAPEUTICS INC Health Care Equity 31994.46 0.97
MEDCL MEDINCELL SA Health Care Equity 31813.75 0.97
CBLL CERIBELL INC Health Care Equity 30698.47 0.94
RGNX REGENXBIO INC Health Care Equity 29982.92 0.91
2172 MICROPORT NEUROTECH CORP Health Care Equity 28109.55 0.86
FULC FULCRUM THERAPEUTICS INC Health Care Equity 26756.32 0.82
CLPT CLEARPOINT NEURO INC Health Care Equity 23354.64 0.71
SLDB SOLID BIOSCIENCES INC Health Care Equity 21871.17 0.67
VNDA VANDA PHARMACEUTICALS INC Health Care Equity 20848.24 0.64
NPCE NEUROPACE INC Health Care Equity 20731.54 0.63
PRTA PROTHENA PLC Health Care Equity 20716.91 0.63
ABEO ABEONA THERAPEUTICS INC Health Care Equity 20595.68 0.63
ANNX ANNEXON INC Health Care Equity 18206.4 0.55
RAPP RAPPORT THERAPEUTICS INC Health Care Equity 15895.26 0.48
DRUG BRIGHT MINDS BIOSCIENCES INC Health Care Equity 15300.46 0.47
NGNE NEUROGENE INC Health Care Equity 14097.85 0.43
TRDA ENTRADA THERAPEUTICS INC Health Care Equity 11706.24 0.36
VYGR VOYAGER THERAPEUTICS INC Health Care Equity 11189.78 0.34
SGMO SANGAMO THERAPEUTICS INC Health Care Equity 10340.45 0.32
LRMR LARIMAR THERAPEUTICS INC Health Care Equity 8811.61 0.27
ALEC ALECTOR INC Health Care Equity 8674.4 0.26
SAVA CASSAVA SCIENCES INC Health Care Equity 6516.0 0.2
USD USD CASH Cash and/or Derivatives Cash 3593.01 0.11
CHF CHF CASH Cash and/or Derivatives Cash 1230.65 0.04
EUR EUR CASH Cash and/or Derivatives Cash 1020.42 0.03
JPY JPY CASH Cash and/or Derivatives Cash 1008.43 0.03
SEK SEK CASH Cash and/or Derivatives Cash 514.13 0.02
AUD AUD CASH Cash and/or Derivatives Cash 407.42 0.01
DKK DKK CASH Cash and/or Derivatives Cash 346.92 0.01
KRW KRW CASH Cash and/or Derivatives Cash 267.88 0.01
HKD HKD CASH Cash and/or Derivatives Cash 31.95 0.0
The content contained herein is owned or licensed by BlackRock and/or its third-party information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. Such content is solely for your personal, non-commercial use. Accordingly, you may not copy, distribute, modify, post, frame or deep link this content. You may download material displayed on this Website for your personal use provided you also retain all copyright and other proprietary notices contained on the materials. Modification or use of the materials for any other purpose violates BlackRock's intellectual property rights. Holdings subject to change. See www.iShares.com for the most recent funds holdings. The values for “price” shown herein generally represent a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The values shown herein for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of the vendor price and may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent practicable date and may not necessarily be as of the date shown above. Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures. CAREFULLY CONSIDER THE FUNDS' INVESTMENT OBJECTIVES, RISK FACTORS, AND CHARGES AND EXPENSES BEFORE INVESTING. THIS AND OTHER INFORMATION CAN BE FOUND IN THE FUNDS' PROSPECTUSES OR, IF AVAILABLE, THE SUMMARY PROSPECTUSES WHICH MAY BE OBTAINED BY VISITING WWW.ISHARES.COM OR WWW.BLACKROCK.COM. READ THE PROSPECTUS CAREFULLY BEFORE INVESTING. INVESTING INVOLVES RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL. This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. The Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Bloomberg, BlackRock Index Services, LLC, Cboe Global Indices, LLC, Cohen & Steers, European Public Real Estate Association (“EPRA® ”), FTSE International Limited (“FTSE”), ICE Data Indices, LLC, NSE Indices Ltd, JPMorgan, JPX Group, London Stock Exchange Group (“LSEG”), MSCI Inc., Markit Indices Limited, Morningstar, Inc., Nasdaq, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), Nikkei, Inc., Russell, S&P Dow Jones Indices LLC or STOXX Ltd. None of these companies make any representation regarding the advisability of investing in the Funds. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above. Neither FTSE, LSEG, nor NAREIT makes any warranty regarding the FTSE Nareit Equity REITS Index, FTSE Nareit All Residential Capped Index or FTSE Nareit All Mortgage Capped Index. Neither FTSE, EPRA, LSEG, nor NAREIT makes any warranty regarding the FTSE EPRA Nareit Developed ex-U.S. Index, FTSE EPRA Nareit Developed Green Target Index or FTSE EPRA Nareit Global REITs Index. “FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. ©2023 BlackRock, Inc or its affiliates. All rights reserved. iSHARES, iBONDS and BLACKROCK are trademarks of BlackRock, Inc. or its affiliates. All other trademarks are those of their respective owners. nan nan nan nan nan